A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Chordoma

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 16, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions

Chordoma

Interventions

DRUG

BL-B01D1

Administration by intravenous infusion for a cycle of 3 weeks.

Trial Locations (1)

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

collaborator

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

INDUSTRY

lead

Sichuan Baili Pharmaceutical Co., Ltd.

INDUSTRY